Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 22670174)

1.

Histologic evaluation of intrahepatic micrometastases in patients treated with or without neoadjuvant chemotherapy for colorectal carcinoma liver metastasis.

Wakai T, Shirai Y, Sakata J, Kameyama H, Nogami H, Iiai T, Ajioka Y, Hatakeyama K.

Int J Clin Exp Pathol. 2012;5(4):308-14. Epub 2012 Apr 16.

2.

Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis.

Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, Ajioka Y, Hatakeyama K.

Ann Surg Oncol. 2008 Sep;15(9):2472-81. doi: 10.1245/s10434-008-0023-y. Epub 2008 Jul 2.

PMID:
18594929
3.
4.

Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.

Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M.

Arch Surg. 2002 Jul;137(7):833-40.

PMID:
12093342
5.

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM.

JAMA. 2009 Dec 2;302(21):2338-44. doi: 10.1001/jama.2009.1755.

6.

Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

Knowles B, Welsh FK, Chandrakumaran K, John TG, Rees M.

HPB (Oxford). 2012 May;14(5):298-309. doi: 10.1111/j.1477-2574.2012.00447.x. Epub 2012 Feb 28.

7.

Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.

Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T.

Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.

PMID:
20844968
8.

[Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].

Kaibori M, Iwamoto S, Ishizaki M, Matsui K, Saito T, Yoshioka K, Kwon AH.

Gan To Kagaku Ryoho. 2009 Dec;36(13):2579-82. Japanese.

PMID:
20009458
9.

Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.

Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, Hayashi H, Okabe H, Ootao R, Watanabe M, Takamori H, Iyama K, Baba H.

Int J Clin Oncol. 2010 Jun;15(3):263-70. doi: 10.1007/s10147-010-0046-9. Epub 2010 Mar 19.

PMID:
20238233
10.

Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.

Cardona K, Mastrodomenico P, D'Amico F, Shia J, Gönen M, Weiser MR, Paty PB, Kingham TP, Allen PJ, De Matteo RP, Fong Y, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2013 Jan;20(1):148-54. doi: 10.1245/s10434-012-2540-y. Epub 2012 Jul 31.

PMID:
22847127
11.

Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment?

Tanaka K, Shimada H, Togo S, Ota M, Yamagichi S, Ike H.

Hepatogastroenterology. 2001 May-Jun;48(39):803-7.

PMID:
11462928
12.

Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Ayez N, Lalmahomed ZS, Eggermont AM, Ijzermans JN, de Jonge J, van Montfort K, Verhoef C.

Ann Surg Oncol. 2012 May;19(5):1618-27. doi: 10.1245/s10434-011-2114-4. Epub 2011 Oct 18.

14.

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.

Seidensticker M, Wust P, Rühl R, Mohnike K, Pech M, Wieners G, Gademann G, Ricke J.

Radiat Oncol. 2010 Mar 24;5:24. doi: 10.1186/1748-717X-5-24.

15.

Hepatic resection for colorectal metastases: analysis of prognostic factors.

Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, Kusashio K, Furuya S, Nakajima N.

Dis Colon Rectum. 1999 May;42(5):632-9.

PMID:
10344686
16.

Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.

Pandanaboyana S, White A, Pathak S, Hidalgo EL, Toogood G, Lodge JP, Prasad KR.

Ann Surg Oncol. 2015 Jan;22(1):173-9. doi: 10.1245/s10434-014-3953-6. Epub 2014 Aug 2.

PMID:
25084766
17.

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H.

Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8.

18.
19.

Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer.

Zhou XP, Quan ZW, Cong WM, Yang N, Zhang HB, Zhang SH, Yang GS.

World J Gastroenterol. 2007 Sep 7;13(33):4498-503.

20.

Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?

Reddy SK, Tsung A, Marsh JW, Geller DA.

J Surg Oncol. 2012 Jan;105(1):55-9. doi: 10.1002/jso.22044. Epub 2011 Aug 12.

PMID:
21842519
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk